BeOne Medicines Achieves Key Regulatory Milestone as EMA Grants PRIME Designation to BTK Degrader BGB-16673 for Waldenstrom’s Macroglobulinemia BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), an emerging global…
Bayer Raises Full-Year Outlook on Strong Pharma Performance, While Setting Aside €1.7 Billion for U.S. Litigation Risks Ahead of its scheduled second-quarter 2025 earnings release on August 6, Bayer AG…
Merck Completes €665 Million Divestment of Surface Solutions Business to GNMI, Marking Strategic Realignment Toward Innovation-Focused Growth In a decisive move underscoring its strategic emphasis on core technological and scientific…
Actio Biosciences Receives FDA IND Clearance and Fast Track Designation for ABS-1230 in KCNT1-Related Epilepsy, Marking Major Advancement in Pediatric Precision Medicine Actio Biosciences, a clinical-stage biotechnology company pioneering novel…
AeroRx Therapeutics Reports Positive Phase 2a Results for Inhaled AERO-007, the First Nebulized LABA/LAMA Combination Therapy in Development for COPD AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in proprietary…
KKR Acquires Majority Stake in HealthCare Royalty Partners, Expanding Life Sciences Strategy and Biopharma Royalty Capabilities KKR & Co. Inc., one of the world’s foremost investment firms, has announced a…
Stallergenes Greer Brings National Spotlight to Peanut Allergy Awareness with Palforzia® Segment on Lifetime TV’s “The Balancing Act” Stallergenes Greer, a global biopharmaceutical company and recognized leader in allergy immunotherapy…
Merz Aesthetics Expands U.S. Leadership Team With Appointment of Sales and Marketing Veterans to Drive National Growth Strategy Merz Aesthetics, the world’s largest company solely dedicated to the field of…
Grifols Reports Strong First Half 2025 Results with Robust Revenue Growth, Rising Profitability, and Strategic Progress Across Business Units Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and a world…
Labcorp Earns IVDR CE-Marking for PGDx elio™ tissue complete, Paving the Way for Expanded Personalized Oncology Testing Across Europe In a milestone achievement that advances the accessibility of precision oncology…
Novo Nordisk Ushers in New Era of Leadership as Maziar Mike Doustdar Is Named President and CEO, Effective August 7, 2025 Novo Nordisk, a global healthcare leader renowned for its…
DecisionRx and BeneCard PBF Unite to Transform Pharmacy Benefits Through Personalized Medication Optimization In a bold move poised to reshape how pharmacy benefits are delivered and experienced across the U.S.,…